FOCLIVIA DIN 02510561
Status: Approved
Holder: SEQIRUS UK LIMITED
Health Canada record
| Active ingredient(s) | HAEMAGGLUTININ-STRAIN A (H5N1) 7.5 MCG |
|---|
| Dosage form | Suspension |
|---|
| Route | Intramuscular |
|---|
| Schedule | SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
|---|
| Original market date | |
|---|
| Current status date | 07-Jan-2021 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HAEMAGGLUTININ-STRAIN A (H5N1)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02401886 | AREPANRIX H5N1 | ID BIOMEDICAL CORPORATION OF QUEBEC | Emulsion | HAEMAGGLUTININ-STRAIN A (H5N1) 3.75 MCG | Marketed |
| 02510588 | FOCLIVIA | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H5N1) 7.5 MCG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 24962 | 2021-01-07 | New Drug Submission (NDS) | |
Request a quote for FOCLIVIA
How to read a Canadian DIN record